Xeris Pharmaceuticals | XERS - 资产

金融业

USD 16.66

USD 423.22M

现金及等价物

USD 131.08M

USD 12.51M

USD 289.27M

USD 134.48M

USD 289.44M

USD -24.15M

USD -20.94M

377

EPS每股收益

USD -0.18

股本和储备

USD 48.78M

USD 79.59M

债务利息支出

USD 6.95M

USD 1.46M

USD 189.71M

USD 2.32B

USD -31.1M

USD 86.93M

USD 5.17M

普通股股本

USD 173.59M

92.28

USD -31.1M

USD 92.1M

销售和管理费用

USD 61.04M

USD 76.93M

贸易债权人

USD 8.04M

应收帐款人

USD 58.11M

	资产	更改		日
Celltrion	KRW 779.18B		10.37B	2026-06
Cspc Pharmaceutical	CNY 46.7B		695.56M	2025-12
Deva Holding AS	TRY 12.93B		1.83B	2023-09
Dianthus Therapeutics	USD 1.28B		62.98M	2026-09
Divis Laboratories Ltd	INR 219.64B		19.31B	2026-09
Eli Lilly	USD 148.07B		5.79B	2026-09
Kangmei Pharma	CNY 13.07B		239.31M	2026-06
Knight Therapeutics	CAD 1.05B		2.28M	2025-12
Laboratorios Farma	EUR 799.88M		99.95M	2023-12
Malin Corporation	EUR 198.5M		70.1M	2024-12
Medical Developments International	AUD 63.57M		2.83M	2025-12
Nektar Therapeutics	USD 763.27M		482.86M	2026-03
Neuren Pharmaceuticals	AUD 342.86M		11.61M	2025-12
Organigram Holdings	CAD 820.26M		298.95M	2026-06
Ovoca Bio	EUR 2.07M		414K	2025-12
Pacira	USD 34.68B		33.44B	2026-09
Perrigo	USD 7.48B		124.6M	2026-09
Pharma Mar	EUR 408.4M		14.8M	2026-09
Qiagen NV	USD 5.89B		107.14M	2026-06
Sartorius	EUR 9.67B		70.9M	2026-09
Sino Biopharmaceutical	CNY 74.89B		9.49B	2025-06
Supernus Pharmaceuticals	USD 1.4B		30.42M	2026-09
Tilray	USD 2.1B		15.95M	2025-09
Zealand Pharma A/S	15.3B		647.8M	2026-03
Zz Pientze Pharmaceu	CNY 17.71B		799.05M	2026-09